mechanism of semaglutide Spotlight on the Action of Semaglutide-Mediated Remodeling of Adipose Tissue

In spring 2025, the Food and Drug Administration (FDA) resolved and ended the GLP-1 medications shortage, subsequently releasing declaratory orders that neither outsourcing compounding pharmacies or pharmacies could compound drugs that were essentially copies of either semaglutide (available under the brand names Ozempic, Rybelsus, and Wegovy) and tirzepatide (available under the brand names Mounjaro, and Zepbound).

Ideal for long-duration metabolic and body composition studies

Leveraging the power of nature & science, Our GLP 1 Supplement provides a sustainable, affordable alternative to weight manager

Pharmaceutical-grade from Simon's Compounding

Ozempic is the only FDA-approved oral peptide GLP-1 medication for adults with type 2 diabetes indicated not only to improve blood sugar, along with diet and exercise, but also to reduce the risk of major cardiovascular events (MACE) such as heart attack, stroke, or death in those who are also at high risk for these events.1 Oral

This article explains the science behind GLP-1 fatigue, when it typically improves, and personalized approaches to managing energy levels throughout your weight loss journey